BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 15847943)

  • 1. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis.
    Bai F; Pei XH; Godfrey VL; Xiong Y
    Mol Cell Biol; 2003 Feb; 23(4):1269-77. PubMed ID: 12556487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
    Dib A; Peterson TR; Raducha-Grace L; Zingone A; Zhan F; Hanamura I; Barlogie B; Shaughnessy J; Kuehl WM
    Cell Div; 2006 Oct; 1():23. PubMed ID: 17049078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.
    Kawamata N; Seriu T; Koeffler HP; Bartram CR
    Cancer; 1996 Feb; 77(3):570-5. PubMed ID: 8630967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of extremely low frequency electromagnetic fields on cyclin-dependent kinase 4 inhibitor gene p18(INK4C) in electric energy workers.
    Erdal N; Erdal ME; Gürgül S
    Arch Med Res; 2005; 36(2):120-3. PubMed ID: 15847943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
    Georgitsi M
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1 mutations and human malignancies.
    Shiohara M; Koike K; Komiyama A; Koeffler HP
    Leuk Lymphoma; 1997 Jun; 26(1-2):35-41. PubMed ID: 9250785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic analysis in the clinical neuro-oncology].
    Ueki K
    No To Shinkei; 2001 Jan; 53(1):41-9. PubMed ID: 11211729
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.